An unprecedented association

Ten pharmaceuticals companies (1) recently grouped together to form the “TransCelerateBioPharma” non-profit organization. The purpose of this organization is to improve the quality of clinical research and to make new and innovative medicaments available to patients more quickly. “TransCelerateBioPharma’s mission is to work together in the field of R&D and to pool the results of our research and our solutions in order to simplify and speed up the release of new medicaments that are of significant interest to patients”, declared Garry Neil, interim CEO of the new organization.

(1) Abbott, AstraZeneca, BoehringerIngelheim, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, Pfizer, Roche and Sanofi